Spine device company Surgalign Holdings has priced an underwritten public offering of 25 million shares of its common stock at $1.50 per share, before underwriting discounts and commissions.
Medtronic released its "2020 Global Inclusion, Diversity and Equity Report" which outlines the company's actions for developing and retaining diverse talent.
During Johnson & Johnson's fourth-quarter earnings call, CEO Alex Gorsky projected elective surgical volumes to be most affected in the first quarter, but hopes improved vaccine distribution will lead to more "normalized levels" toward the end of the year, according to The Motley Fool.
The FDA has granted clearance for the Trident SI joint screw system, developed by surgeons from Burnsville, Minn.-based Inspired Spine, according to a Jan. 26 news release.
Johnson & Johnson's orthopedics sales dropped 12.2 percent year over year in 2020 to $7.7 billion. Sales declined 10.2 percent in the U.S. and 15.2 percent worldwide.
Orthopedic device company Sacrix launched the third iteration of SacroFuse, a threaded compression device designed for immediate stabilization of the sacroiliac joint.